Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance
Radheshyam Meher, Senior Resident at AIIMS, psoted on LinkedIn:
”Exciting Announcement
I am honored to serve as Guest Editor for a special collection in Cureus on:
“Artificial Intelligence in Transfusion Medicine: From Donor Recruitment to Hemovigilance”
This collection will highlight how AI is reshaping every step of the transfusion medicine journey, from innovative donor recruitment and retention strategies to predictive inventory management, AI-driven blood safety and pathogen detection, automated hemovigilance, and advanced clinical decision support.
We welcome original research, reviews, case studies, and perspectives that showcase both technological innovation and real-world applications, while also addressing the ethical and regulatory challenges of AI in healthcare.
Our aim is to bring together a global, interdisciplinary perspective that bridges digital health, transfusion science, and clinical practice, ultimately driving improvements in efficiency, safety, and patient outcomes.
Topics include (but are not limited to):
- AI for donor recruitment and retention
- Predictive analytics for transfusion needs
- Machine learning in inventory management
- Automated hemovigilance and adverse event monitoring
- AI in therapeutic apheresis and cellular therapies
- NLP in transfusion data
- Ethical and regulatory considerations
I invite researchers, clinicians, data scientists, and innovators to submit your work and be part of this forward-looking initiative.
Let’s work together to shape the future of AI in Transfusion Medicine.
Submit here.”
Stay updated with Hemostasis Today.
-
Oct 23, 2025, 06:03Melanie Daniel: Wonderful Presentation on Emicizumab by Mickael Rosa at ECTH
-
Oct 22, 2025, 06:17We Will Continue to Raise Awareness and Remind Rveryone That Donating Blood Means Saving Lives - Yeolyan Hematology and Oncology Center
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 21, 2025, 05:20Ewa Fiorentino Rozek: APS - When “Unprovoked” Clots And Pregnancy Loss Connect
-
Oct 23, 2025, 06:48Omid Seidizadeh Shares Deep Molecular Modeling and Mechanistic Insights into Type 2A VWD
-
Oct 23, 2025, 06:45Mélanie Roussel on D-Dimer Thresholds for Diagnosis of Pulmonary Embolism
-
Oct 23, 2025, 06:28Ramya Ramakrishnan on IDA Association with Depression
-
Oct 23, 2025, 06:07Cedric Hermans: Von Willebrand Disease Diagnosis - From Complexity to Simplicity
-
Oct 23, 2025, 05:45Andrew Larry Frelinger III on Activation of Platelets in Flow Cytometry
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 23, 2025, 06:52Louise Bannon: Thrilled to Witness The Incredible Reach of This Year's World Thrombosis Day!
-
Oct 23, 2025, 06:50Caitlin Raymond to Speak at The 11th Annual Bloodless Medicine and Surgery Society Conference
-
Oct 22, 2025, 10:46Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
-
Oct 22, 2025, 10:32Lynn Malec - The New Director of the CCBD and Pharmacy at Children's Wisconsin
-
Oct 22, 2025, 09:41Deanna Joseph: Feeling Inspired and Deeply Grateful After Attending the 2025 HTRS SEARCH Workshop